메뉴 건너뛰기




Volumn 13, Issue 1, 2011, Pages 11-17

Pediatric asthma controller therapy

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; SALBUTAMOL; SALMETEROL; TERBUTALINE;

EID: 78650322287     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11533730-000000000-00000     Document Type: Article
Times cited : (4)

References (26)
  • 4
    • 39049170984 scopus 로고    scopus 로고
    • Global strategy for asthma management and prevention: GINA executive summary
    • Jan
    • Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 Jan; 31 (1): 143-78
    • (2008) Eur Respir J , vol.31 , Issue.1 , pp. 143-178
    • Bateman, E.D.1    Hurd, S.S.2    Barnes, P.J.3
  • 5
    • 0034642066 scopus 로고    scopus 로고
    • Long-term effects of budesonide or nedocromil in children with asthma
    • The Childhood Asthma Management Program Research Group Oct 12
    • The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000 Oct 12; 343 (15): 1054-63
    • (2000) N Engl J Med , vol.343 , Issue.15 , pp. 1054-1063
  • 6
    • 0034642055 scopus 로고    scopus 로고
    • Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
    • Oct 12
    • Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000 Oct 12; 343 (15): 1064-9
    • (2000) N Engl J Med , vol.343 , Issue.15 , pp. 1064-1069
    • Agertoft, L.1    Pedersen, S.2
  • 7
    • 64149130397 scopus 로고    scopus 로고
    • Long-termbudesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents
    • May
    • Strunk RC, Sternberg AL, Szefler SJ, et al. Long-termbudesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009May; 154 (5): 682-7
    • (2009) J Pediatr , vol.154 , Issue.5 , pp. 682-687
    • Strunk, R.C.1    Sternberg, A.L.2    Szefler, S.J.3
  • 8
    • 48249098293 scopus 로고    scopus 로고
    • Effect of long-term corticosteroid use on bonemineral density in children: A prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study
    • Jul
    • Kelly HW, Van Natta ML, Covar RA, et al. Effect of long-term corticosteroid use on bonemineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008 Jul; 122 (1): e53-61
    • (2008) Pediatrics , vol.122 , Issue.1
    • Kelly, H.W.1    Van Natta, M.L.2    Covar, R.A.3
  • 9
    • 33846032661 scopus 로고    scopus 로고
    • Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial
    • Jan
    • Sorkness CA, Lemanske Jr RF, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007 Jan; 119 (1): 64-72
    • (2007) J Allergy Clin Immunol , vol.119 , Issue.1 , pp. 64-72
    • Sorkness, C.A.1    Lemanske Jr., R.F.2    Mauger, D.T.3
  • 10
    • 33749185890 scopus 로고    scopus 로고
    • Treatment with 400 microg of inhaled budesonide versus 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: Randomized controlled trial
    • Sep
    • Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide versus 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. Ann Allergy Asthma Immunol 2006 Sep; 97 (3): 397-401
    • (2006) Ann Allergy Asthma Immunol , vol.97 , Issue.3 , pp. 397-401
    • Jat, G.C.1    Mathew, J.L.2    Singh, M.3
  • 11
    • 43949129790 scopus 로고    scopus 로고
    • Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review
    • May
    • Joos S, Miksch A, Szecsenyi J, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008 May; 63 (5): 453-62
    • (2008) Thorax , vol.63 , Issue.5 , pp. 453-462
    • Joos, S.1    Miksch, A.2    Szecsenyi, J.3
  • 12
    • 1842370350 scopus 로고    scopus 로고
    • Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
    • Nov 13
    • Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997 Nov 13; 337 (20): 1405-11
    • (1997) N Engl J Med , vol.337 , Issue.20 , pp. 1405-1411
    • Pauwels, R.A.1    Lofdahl, C.G.2    Postma, D.S.3
  • 13
    • 5144221336 scopus 로고    scopus 로고
    • Can guideline-defined asthma control be achieved? the Gaining Optimal Asthma Control study
    • Oct 15
    • Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004 Oct 15; 170 (8): 836-44
    • (2004) Am J Respir Crit Care Med , vol.170 , Issue.8 , pp. 836-844
    • Bateman, E.D.1    Boushey, H.A.2    Bousquet, J.3
  • 14
    • 68149179757 scopus 로고    scopus 로고
    • Salmeterol/fluticasone propionate versus double dose fluticasone propionate on lung function and asthma control in children
    • Dec
    • de Blic J, Ogorodova L, Klink R, et al. Salmeterol/fluticasone propionate versus double dose fluticasone propionate on lung function and asthma control in children. Pediatr Allergy Immunol 2009 Dec; 20 (8): 763-71
    • (2009) Pediatr Allergy Immunol , vol.20 , Issue.8 , pp. 763-771
    • De Blic, J.1    Ogorodova, L.2    Klink, R.3
  • 15
    • 0029758728 scopus 로고    scopus 로고
    • Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action
    • van Noord JA, Smeets JJ, Raaijmakers JA, et al. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9 (8): 1684-8
    • (1996) Eur Respir J , vol.9 , Issue.8 , pp. 1684-1688
    • Van Noord, J.A.1    Smeets, J.J.2    Raaijmakers, J.A.3
  • 16
    • 12144270425 scopus 로고    scopus 로고
    • Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma
    • Jan 15
    • OByrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005 Jan 15; 171 (2): 129-36
    • (2005) Am J Respir Crit Care Med , vol.171 , Issue.2 , pp. 129-136
    • Obyrne, P.M.1    Bisgaard, H.2    Godard, P.P.3
  • 17
    • 33845928663 scopus 로고    scopus 로고
    • Budesonide/formoterol maintenance plus reliever therapy: A new strategy in pediatric asthma
    • Dec
    • Bisgaard H, Le RP, Bjamer D, et al. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006 Dec; 130 (6): 1733-43
    • (2006) Chest , vol.130 , Issue.6 , pp. 1733-1743
    • Bisgaard, H.1    Le Bjamer, R.P.D.2
  • 18
    • 44949194776 scopus 로고    scopus 로고
    • Regular treatment with salmeterol for chronic asthma: Serious adverse events
    • Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008; (3): CD006363
    • (2008) Cochrane Database Syst Rev , Issue.3
    • Cates, C.J.1    Cates, M.J.2
  • 19
    • 44949194776 scopus 로고    scopus 로고
    • Regular treatment with formoterol for chronic asthma: Serious adverse events
    • Cates CJ, Cates MJ, Lasserson TJ. Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008; (4): CD006923
    • (2008) Cochrane Database Syst Rev , Issue.4
    • Cates, C.J.1    Cates, M.J.2    Lasserson, T.J.3
  • 20
    • 70049106524 scopus 로고    scopus 로고
    • Regular treatment with formoterol and inhaled steroids for chronic asthma: Serious adverse events
    • Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009; (2): CD006924
    • (2009) Cochrane Database Syst Rev , Issue.2
    • Cates, C.J.1    Lasserson, T.J.2    Jaeschke, R.3
  • 21
    • 70049106524 scopus 로고    scopus 로고
    • Regular treatment with salmeterol and inhaled steroids for chronic asthma: Serious adverse events
    • Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009; (3): CD006922
    • (2009) Cochrane Database Syst Rev , Issue.3
    • Cates, C.J.1    Lasserson, T.J.2    Jaeschke, R.3
  • 22
    • 77949576423 scopus 로고    scopus 로고
    • Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
    • Lemanske Jr RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362 (11): 975-85
    • (2010) N Engl J Med , vol.362 , Issue.11 , pp. 975-985
    • Lemanske Jr., R.F.1    Mauger, D.T.2    Sorkness, C.A.3
  • 23
    • 18144383000 scopus 로고    scopus 로고
    • Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide
    • May
    • Agertoft L, Pedersen S. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J Allergy Clin Immunol 2005 May; 115 (5): 940-5
    • (2005) J Allergy Clin Immunol , vol.115 , Issue.5 , pp. 940-945
    • Agertoft, L.1    Pedersen, S.2
  • 24
    • 77954142714 scopus 로고    scopus 로고
    • Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate
    • Feb
    • Agertoft L, Pedersen S. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate. Pediatr Allergy Immunol 2010 Feb; 21 (1 Pt II): e199-205
    • (2010) Pediatr Allergy Immunol , vol.21 , Issue.1 PART 2
    • Agertoft, L.1    Pedersen, S.2
  • 25
    • 34447116988 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of ciclesonide 160 microg once daily versus budesonide 400 microg once daily in children with asthma
    • Aug
    • von Berg A, Engelstatter R, Minic P, et al. Comparison of the efficacy and safety of ciclesonide 160 microg once daily versus budesonide 400 microg once daily in children with asthma. Pediatr Allergy Immunol 2007 Aug; 18 (5): 391-400
    • (2007) Pediatr Allergy Immunol , vol.18 , Issue.5 , pp. 391-400
    • Von Berg, A.1    Engelstatter, R.2    Minic, P.3
  • 26
    • 33749565533 scopus 로고    scopus 로고
    • A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma
    • Oct
    • Pedersen S, Garcia Garcia ML, Manjra A, et al. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pediatr Pulmonol 2006 Oct; 41 (10): 954-61
    • (2006) Pediatr Pulmonol , vol.41 , Issue.10 , pp. 954-961
    • Pedersen, S.1    Garcia Garcia, M.L.2    Manjra, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.